Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DiaSys sees growth in Middle East IDD (infectious disease diagnostics) market:

This article was originally published in Clinica

Executive Summary

There is an expanding market for infectious disease diagnostics in the Middle East and Pakistan, driven by World Health Organization initiatives to eradicate major infectious diseases, increasing international travel and immigration, and growing interest in standardisation and accreditation among healthcare authorities. So says DiaSys, the Waterbury, Connecticut test maker that has just signed distribution deals in the region. Distributors in Kuwait, Oman, Bahrain and Pakistan will exclusively promote, sell and service diagnostic products including tools for analysing parasites in human body fluids, urine sediment analysis products and a range of rapid tests for infectious diseases.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel